0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Hemagglutinin (HA)

Hemagglutinin (HA)

Brief Information

Name:Influenza virus hemagglutinin glycoproteins
Target Synonym:Hemagglutinin,HA,Hemagglutinin Glycoproteins, Influenza Virus
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:8
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Part of Bioactivity data

HA2-V5227-ELISA
Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] HA, His TagInfluenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] HA, His Tag (Cat. No. HA2-V5227) ELISA bioactivity

Immobilized Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] HA, His Tag (Cat. No. HA2-V5227) at 2 μg/mL (100 μL/well) can bind Anti-Influenza HA MAb CM2S3 with a linear range of 0.4-3 ng/mL (QC tested).

HA1-V5229-MALS-HPLC
Influenza A [A/Hong Kong/483/97 (H5N1)] HA, His Tag (Cat. No. ) MALS images

The purity of Influenza A [A/Hong Kong/483/97 (H5N1)] HA, His Tag (Cat. No. HA1-V5229) was more than 90% and the molecular weight of this protein is around 95-110 kDa verified by SEC-MALS.

Bioactivity-ELISA
Influenza A [A/Hong Kong/483/97 (H5N1)] HA, His TagInfluenza A [A/Hong Kong/483/97 (H5N1)] HA, His Tag (Cat. No. HA1-V5229) ELISA bioactivity

Immobilized Influenza A [A/Hong Kong/483/97 (H5N1)] HA, His Tag (Cat. No. HA1-V5229) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Influenza HA Universal Antibody, Human IgG1 with a linear range of 2-78 ng/mL (QC tested).

cies Influenzavirus A (avian influenza virus or bird flu virus). H7 normally circulates amongst avian populations with some variants known to occasionally infect humans. An H7N9 virus was first reported to have infected humans in 2013 in China.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Anti-influenza monoclonal antibody (AIMM Therapeutics) Phase 1 Clinical Aimm Therapeutics Influenza, Human Details
CT-P27 CT-P27 Phase 2 Clinical Celltrion Influenza A virus infections Details
VIS-410 VIS-410 Phase 2 Clinical Visterra Influenza A virus infections; Influenza, Human Details
mRNA-1851 mRNA-1851; VAL-339851 Phase 1 Clinical Modernatx, Valera Llc Influenza A virus infections; Influenza, Human Details
Influenza vaccine quadrivalent (Nitto/Osaka) NSV-0001 Phase 1 Clinical Osaka University, Nitto Denko Influenza, Human Details
Gedivumab RG-7745; MHAA-4549A Phase 2 Clinical Genentech Inc Influenza A virus infections; Influenza, Human Details
Diridavumab CR-6261; JNJ-54235025 Phase 2 Clinical Crucell Holland Bv Influenza, Human Details
MEDI-8852 MEDI-8852 Phase 2 Clinical Humabs Biomed Influenza, Human Details

This web search service is supported by Google Inc.

totop